Facilitated By

San Antonio Medical Foundation

Development of small molecule inhibitors of protein kinase C epsilon (PKC??) for treatment of acute and chronic pain

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
McHardy Stanton
Funded by
Univ of TX at Austin 721
Research Start Date
Status
Inactive

Basic Research

Collaborative Project
Basic Research
Drug Discovery
Neuroscience